93 related articles for article (PubMed ID: 7517683)
21. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
22. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
Haerslev T; Jacobsen GK; Zedeler K
Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
[TBL] [Abstract][Full Text] [Related]
23. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
Kordek R; Biernat W; Alwasiak J; Liberski PP
Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
[TBL] [Abstract][Full Text] [Related]
24. [Expression of proliferation markers PCNA and MIB 1 in verrucous squamous epithelial carcinoma of the oral cavity].
Theegarten D; Barfuss A; Gellrich NC; Philippou S
Mund Kiefer Gesichtschir; 1997 May; 1(3):133-6. PubMed ID: 9410620
[TBL] [Abstract][Full Text] [Related]
25. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
26. Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma.
Lu EM; Ratnayake J; Rich AM
BMC Oral Health; 2019 Oct; 19(1):233. PubMed ID: 31672124
[TBL] [Abstract][Full Text] [Related]
27. Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck.
Alaeddini M; Etemad-Moghadam S
Braz J Otorhinolaryngol; 2022; 88(4):529-532. PubMed ID: 32972865
[TBL] [Abstract][Full Text] [Related]
28. Enhanced polymer one-step staining for proliferating cell nuclear antigen in squamous cell carcinoma of the tongue.
Sano K; Sekine J; Inokuchi T; Pe MB; Ma G
Biotech Histochem; 1996 Nov; 71(6):273-7. PubMed ID: 8957552
[TBL] [Abstract][Full Text] [Related]
29. A novel approach to biomarker discovery in head and neck cancer using an autoantibody signature.
Russo N; Wang X; Liu M; Banerjee R; Goto M; Scanlon C; Metwally T; Inglehart RC; Tsodikov A; Duffy S; Van Tubergen E; Bradford C; Carey T; Wolf G; Chinnaiyan AM; D'Silva NJ
Oncogene; 2013 Oct; 32(42):5026-37. PubMed ID: 23160375
[TBL] [Abstract][Full Text] [Related]
30. Could NSP5a3a be a target for head and neck cancer?
White MK; Khalili K
Oncotarget; 2010 Oct; 1(6):386. PubMed ID: 21311094
[No Abstract] [Full Text] [Related]
31. Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
Szczepanski MJ; Whiteside TL
Biomark Med; 2013 Aug; 7(4):575-8. PubMed ID: 23905893
[No Abstract] [Full Text] [Related]
32. Immunohistochemical detection of nucleolar protein p120 in paraffin-embedded tissues.
Migaldi M; Barbolini G; Trerè D; Criscuolo M; Martinelli AM; Zunarelli E
Histochem J; 1997 Sep; 29(9):661-8. PubMed ID: 9413739
[TBL] [Abstract][Full Text] [Related]
33. Prognostic relevance of cell proliferation in head and neck tumors.
Pich A; Chiusa L; Navone R
Ann Oncol; 2004 Sep; 15(9):1319-29. PubMed ID: 15319236
[TBL] [Abstract][Full Text] [Related]
34. Inter-component immunohistochemical assessment of proliferative markers in uterine carcinosarcoma.
Pyra A; Adamiak-Godlewska A; Lewkowicz D; Bałon B; Cybulski M; Semczuk-Sikora A; Semczuk A
Oncol Lett; 2022 Oct; 24(4):363. PubMed ID: 36238851
[TBL] [Abstract][Full Text] [Related]
35. Histological and microscopy FT-IR imaging study on the proliferative activity and angiogenesis in head and neck tumours.
Bruni P; Conti C; Giorgini E; Pisani M; Rubini C; Tosi G
Faraday Discuss; 2004; 126():19-26; discussion 77-92. PubMed ID: 14992397
[TBL] [Abstract][Full Text] [Related]
36. Robust multiparametric assessment of cellular senescence.
Correia-Melo C; Jurk D; Passos JF
Methods Mol Biol; 2013; 965():409-19. PubMed ID: 23296674
[TBL] [Abstract][Full Text] [Related]
37. PCNA and Ki67: Prognostic proliferation markers for oral cancer.
Jayaraman S; Pazhani J; PriyaVeeraraghavan V; Raj AT; Somasundaram DB; Patil S
Oral Oncol; 2022 Jul; 130():105943. PubMed ID: 35653815
[No Abstract] [Full Text] [Related]
38. Simultaneous detection of DNA fragmentation (apoptosis), cell proliferation (MIB-1), and phenotype markers in routinely processed tissue sections.
Bonkhoff H; Fixemer T; Hunsicker I; Remberger K
Virchows Arch; 1999 Jan; 434(1):71-3. PubMed ID: 10071238
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of cell proliferation markers in breast carcinomas.
Leong AS; Vinyuvat S; Suthipintawong C; Milios J
Clin Mol Pathol; 1995 Apr; 48(2):M83-7. PubMed ID: 16695987
[TBL] [Abstract][Full Text] [Related]
40. Comparative scoring by visual and image analysis of cells in human solid tumors labeled for proliferation markers.
Weaver JR; Au JL
Cytometry; 1997 Feb; 27(2):189-99. PubMed ID: 9012386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
